title: [Safety evaluation of paclitaxel injection NK in adjuvant therapy for breast cancer].
abstract: A paclitaxel injection NK (NK) is a generic product containing the same amount of ingredients as a Taxol Injection. We examined the safety of NK in clinical practice compared to the original drug. Our results suggested that the safety of NK and the original drug are similar in adjuvant therapy for breast cancer.
authors.affiliation: Osaka Breast Clinic.
authors.forename: Sachiko
authors.initials: S
authors.lastname: Takahara
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Yamamoto
authors.forename: Yuko
authors.initials: Y
authors.lastname: Tokushima
authors.forename: Eiichi
authors.initials: E
authors.lastname: Shiba
mesh_terms: D000328:Adult; D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel